Sandoz Recalls Triamterene and Hydrochlorothiazide Tablets Due to Cross-Contamination
Sandoz Incorporated is recalling specific lots of Triamterene and Hydrochlorothiazide Tablets due to the presence of unrelated ingredients.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The agency classified this as an FDA Class III recall, which is defined as unlikely to cause adverse health consequences. The hazard involves cross-contamination with unrelated ingredients, which fits the criteria for a moderate severity rating involving low-risk contamination or voluntary precautionary measures.
Plain-English summary
Sandoz Incorporated is recalling 11,680 bottles of Triamterene and Hydrochlorothiazide Tablets, USP, 75 mg/50 mg, 500-count bottles. The affected product is prescription-only and was distributed nationwide in the USA and Puerto Rico. The specific lots involved are GW8264 and HD3095, with an expiration date of 12/18.
The recall was initiated because of cross-contamination with other products. The source text indicates the presence of unrelated ingredients, specifically traces of Lisinopril, Mannitol, Iron, Calcium, and Phosphorous.
Consumers should check their medication for the NDC 0781-5067-05 and the lot numbers GW8264 or HD3095. If the product matches these details, patients should contact their healthcare provider or pharmacist for guidance on discontinuing use and obtaining a replacement.
The recalled product
- Product
- Triamterene and Hydrochlorothiazide Tablets, USP, 75 mg/50 mg, 500-count bottles, Rx only, Manufactured by Sandoz, Inc., Princeton, NJ 08540, NDC 0781-5067-05.
- Manufacturer
- Sandoz Incorporated
- Category
- Drug — Prescription Medication
- Affected units
- 11,680
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: GW8264
- HD3095
- Exp 12/18
Distribution
Related recalls
Same manufacturer · Sandoz Incorporated
See all →- ModerateSandoz Recalls Amitriptyline Hydrochloride Tablets Due to Cross-Contamination
FDA (Drugs) · 2017-07-12
- ModerateSandoz Recalls Nadolol Tablets Due to Failed Dissolution Test
FDA (Drugs) · 2017-01-04
- LowSandoz Recalls Fluoxetine Capsules Due to Illegible Logo
FDA (Drugs) · 2014-12-17
- SevereSandoz Recalls Alprazolam Tablets Due to Stainless Steel Particulates
FDA (Drugs) · 2014-08-06
- SevereSandoz Recalls Tacrolimus Capsules Due to Fluvastatin Cross-Contamination
FDA (Drugs) · 2014-01-01
Same hazard · cross contamination
See all →- CriticalCetirizine Hydrochloride Tablets Recalled Due to Cross Contamination with Ranitidine
FDA (Drugs) · 2026-07-29
- ModeratePrimidone tablets recalled over potential acemetacin cross-contamination at API manufacturer
FDA (Drugs) · 2026-06-17
- HighFly By Jing creamy sesame noodles may contain undeclared peanut
FDA (Food) · 2026-06-03
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets 50 mg Recalled for API Cross-Contamination
FDA (Drugs) · 2026-05-27